| DFSTX | IVPSX | DFSTX / IVPSX | |
| Total Expense Ratio | 0.27 | 1.12 | 24% |
| Annual Report Gross Expense Ratio | 0.28 | 1.27 | 22% |
| Fund Existence | 35 years | 25 years | - |
| Gain YTD | 16.572 | 7.102 | 233% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 19.4B | 206M | 9,417% |
| Annual Yield % from dividends | 0.97 | 0.00 | - |
| Returns for 1 year | 17.08 | 9.75 | 175% |
| Returns for 3 years | 53.55 | 17.16 | 312% |
| Returns for 5 years | 36.53 | -22.57 | -162% |
| Returns for 10 years | 110.94 | -18.98 | -585% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DDTD | 20.81 | 0.14 | +0.66% |
| Innovator Equity Dual Dir 10 Buf ETF-Dec | |||
| XTN | 102.41 | 0.55 | +0.54% |
| State Street® SPDR® S&PTrsptnETF | |||
| JHCB | 20.49 | 0.01 | +0.04% |
| JHancock Corporate Bond ETF | |||
| USMD | 30.44 | N/A | N/A |
| Corevalues America First Technology ETF | |||
| IHE | 101.07 | -0.20 | -0.20% |
| iShares US Pharmaceuticals ETF | |||